Effect of renin-angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look AHEAD) trial

Wharton, W., Anderson, A., Hayden, K. M., Carmichael, O. T., Clark, J. M., Luchsinger, J. A., Espeland, M., & Yasar, S. (2022). Effect of renin‐angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look AHEAD) trial. Diabetes, Obesity and Metabolism, 24(12), 2443–2453. Portico. https://doi.org/10.1111/dom.14838
Authors:
Whitney Wharton
Andrea Anderson
Kathleen M Hayden
Owen T Carmichael
Jeanne M Clark
José A Luchsinger
Mark Espeland
Sevil Yasar
Affiliated Authors:
José A Luchsinger
Columbia Affiliation:
Subjects:
Diabetes Mellitus, Type 2 (MeSH)
Cognitive Dysfunction (MeSH)
Dementia (MeSH)
Author Keywords:
antihypertensive medications
cognitive decline
cognitive impairment
dementia
obesity
overweight
renin angiotensin system
type 2 diabetes
elink
Publication Type:
Article
Unique ID:
10.1111/dom.14838
PMID:
36065050
DOI:
10.1111/dom.14838
Journal:
Diabetes, Obesity and Metabolism
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: